摘要
目的:研究吡非尼酮片在中国健康人体的药动学特征。方法:采用Inspire-C_(18)(150 mm×4.6 min,5μm,Dikma)分析柱,甲醇-水含0.2%的磷酸(59:41)为流动相,检测波长为310 nm,流速为1 ml·min^(-1);血浆样品经10%高氯酸溶液沉淀蛋白后直接进样。30名健康受试者随机分为低、中、高3个剂量组,每组10人(男女各半),分别单次口服吡非尼酮片200,400,600 mg,采用HPLC测定血浆中吡非尼酮的浓度并采用WinNonLin 6.2计算药动学参数。结果:人血浆中吡非尼酮的最低定量限为0.2μg·ml^(-1),在0.2~25μg·ml^(-1)范围内线性关系良好,批内及批间精密度RSD均小于15%。主要药动学参数:C_(max)分别为(6.08±6.08)、(11.97±1.34)和(15.71±1.74)μg·ml^(-1);t_(max)分别为(0.63±0.13)、(0.63±0.23)和(0.58±0.19)h;t_(1/2)分别为(2.02±0.47)、(2.15±0.50)和(2.59±0.56)h;AUC_(0-t)分别为(14.79±3.04)、(29.54±8.50)和(47.02±5.85)μg·h·ml^(-1);AUC_(0-∞)分别为(15.77±3.21)、(30.67±9.15)和(50.06±6.07)μg·h·ml^(-1)。结论:3个剂量组(200~600 mg)中吡非尼酮在人体内的AUC_(0-t),AUC_(0-∞)和C_(max)均与剂量呈线性关系。
Objective:To study the pharmacokinetics of pirfenidone tablets in Chinese healthy volunteers.Method:The plasma samples were analyzed on an Inspire-C_(18)(150 mm×4.6 mm,5μm,Dikma) column with methanol-water(0.2%phosphoric acid) (59:41) as the mobile phase.The flow rate was 1 ml ? min^(-1) and the detection wavelength was 310 nm.The samples were denatured by 10%perchloric acid.Thirty healthy volunteers were randomly divided into three groups with 10 volunteers in each group(5 males and 5 females).The three groups received pirfenidone tablets with a single dose of 200,400 and 600 mg,respectively.The concentrations of pirfenidone in human plasma at different times were determined by HPLC and the pharmacokinetic parameters were calculated by WinNonLin 6.2 software.Result:The limit of quantitation(LOQ) of pirfenidone was 0.2μg ? ml^(-1).The calibration curve was linear over the range of 0.2-25μg ? ml^(-1).The intra- and inter-day RSDs were less than 15%.The pharmacokinetic parameters were as follows;C_(max) of(6.08±6.08),(11.97±1.34)and(15.71±1.74)μg ? ml^(-1),t_(max) of(0.63±0.13),(0.63±0.23)and(0.58±0.19)h,t_(1/2)of(2.02±0.47),(2.15±0.50) and(2.59±0.56)h,AUC_(0-t) of(14.79±3.04),(29.54±8.50)and(47.02±5.85)μg·h·ml^(-1),and AUC_(0-∞) of(15.77±3.21),(30.67±9.15) and(50.06±6.07)μg ? h ? ml^(-1).Conclusion:The values of AUC_(0-t),AUC_(0-∞) and C_(max) are linear within the dose range of 200-600 mg.
出处
《中国药师》
CAS
2013年第1期40-43,共4页
China Pharmacist